HCW Biologics is trading at $3.40 (+6.25%) after extending a sharp two-day rally tied to its $1.6 million private placement.

  • The stock's upward momentum follows a 22.09% surge on July 30 and a further 1.59% gain on July 31 (closing price).
  • Investors continue to react favorably to the capital raise, which is expected to provide the company with improved liquidity.